Health ❯ Research ❯ Clinical Research
Combination Therapies Clinical Trials Monoclonal Antibodies Matrix Metalloproteinase Inhibitors
Researchers report delayed deficits after blocking matrix metalloproteinases in a mouse model, suggesting a non-amyloid route for future treatment.